Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

UFS cracks down on crime on campus
2006-03-15

A comprehensive plan to step up the security on the Main Campus of the University of the Free State (UFS) in Bloemfontein, was approved by the Executive Management (EM) this week.

“The plan briefly comprises of the introduction of reasonable and affordable measures that will promote a safe campus and working environment,” said Rev Kiepie Jaftha, Chief Director: Community Service at the UFS.

“With the plan we want to try and create a user friendly, but safe campus,” said Rev Jaftha.

The plan is the result of an intensive investigation about campus security done by an EM task team.

The following measures will be implemented immediately in phases:

The five current vehicle entrances and exits will remain (i.e. the gate at Nelson Mandela Avenue, the gate at Roosmaryn, the gate at Agriculture, the Wynand Mouton Avenue gate and the Furstenburg Road gate).

The number of smaller pedestrian gates will be reduced and security at those remaining will be increased.
The fences around the campus will remain, upgraded and patrolled on a daily basis.

The security measures at high risk areas (e.g. the Kovsie Church) will be stepped up and the fences in these areas will be electrified.

Vehicle exit control will be stepped up at the gates by means of a mixture of electronic and compulsory visual security control.

Public areas, streets and footpaths will be patrolled and shrubs and trees will be cut and pruned. The streets, footpaths and buildings will also be lit. 

Speed reducing mechanisms will be implemented before and after the security control points at all the gates.
Additional staff will be appointed to facilitate the flow of traffic at the gates.

“Over and above these measures, the EM also approved in principle the installation of electronic equipment at all the entrance gates. This will include the installation of cameras,” said Rev Jaftha.

According to Rev Jaftha the installation of the electronic equipment will be complemented by the compulsory cutting and restarting of engines for all vehicles exiting the gates. The measure has been in force since 1 February 2006.

Last year special measures were put in place to safeguard residences and their inhabitants when security guards were placed at all the ladies residences. These measures will stay in force.

“Regular audits will be done to determine the effectiveness of the strategies and systems. Although crime in and around the campus grounds can never be completely eradicated, we want to strive to create an environment on campus and in the workplace where it can be limited,” he said.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
15 March 2006

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept